6:03 AM ET
8-K
Other 8-K Filing
Oaktree Acquisition Corp. III Life Sciences Other 8-K Filing
Oaktree Acquisition Corp. III Life Sciences held an extraordinary general meeting where shareholders approved an amendment to extend the deadline for completing an initial business combination from October 25, 2026, to as late as May 25, 2027. Additionally, the company's Sponsor converted 4,798,758 Class B ordinary shares into Class A ordinary shares on a one-for-one basis.
- Term
- up to 7 months